Children
Sign in to add trainee| Robert P. Hymes | grad student | Columbia (History of History Tree) | |
| Yiching Wu | grad student | Columbia (LinguisTree) | |
| Aihwa Ong | grad student | 1982 | Columbia |
| Eugene Murphy | grad student | 1994 | Columbia |
| Gregory Ruf | grad student | 1994 | Columbia |
| Dee Mack Williams | grad student | 1996 | Columbia |
| Hong Zhang | grad student | 1998 | Columbia |
| Isabelle Rey-Lescure | grad student | 1999 | Columbia |
| Shao-hua Liu | grad student | 2007 | Columbia |
| Ka-ming Wu | grad student | 2007 | Columbia |
| Drew Hopkins | grad student | 2008 | Columbia |
| Yi Wu | grad student | 2010 | Columbia |
| Guangtian Ha | grad student | 2014 | Columbia |
| Yixin Li | grad student | 2014 | Columbia |
| Diana Szatkowski | grad student | 2015 | Columbia |
| Tzu-chi Ou | grad student | 2018 | Columbia |
| Matthew West | grad student | 2019 | Columbia |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Juraska M, Bai H, deCamp AC, et al. (2024) Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features. Proceedings of the National Academy of Sciences of the United States of America. 121: e2308942121 |
| Hall M, Golubchik T, Bonsall D, et al. (2023) Demographics of sources of HIV-1 transmission in Zambia: a molecular epidemiology analysis in the HPTN 071 PopART study. The Lancet. Microbe |
| Huang Y, Zhang L, Karuna S, et al. (2023) Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01. Nature Communications. 14: 7813 |
| Landovitz RJ, Hanscom BS, Clement ME, et al. (2023) Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial. The Lancet. Hiv |
| Matoga M, Chen JS, Massa C, et al. (2023) HIV and urethritis: Time required for antiretroviral therapy to suppress HIV in semen. Aids (London, England) |
| Kovarova M, Wessel SE, Johnson CE, et al. (2023) EFdA efficiently suppresses HIV replication in the male genital tract and prevents penile HIV acquisition. Mbio. e0222422 |
| Seaton KE, Huang Y, Karuna S, et al. (2023) Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition. Ebiomedicine. 93: 104590 |
| Zhou S, Long N, Moeser M, et al. (2023) Use of Next Generation Sequencing in a State-Wide Strategy of HIV-1 Surveillance: Impact of the SARS-CoV-2 Pandemic on HIV-1 Diagnosis and Transmission. The Journal of Infectious Diseases |
| Marzinke MA, Fogel JM, Wang Z, et al. (2023) Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083. Antimicrobial Agents and Chemotherapy. e0005323 |
| Eshleman SH, Fogel JM, Halvas EK, et al. (2022) HIV RNA screening reduces integrase strand transfer inhibitor resistance risk in persons receiving long-acting cabotegravir for HIV prevention. The Journal of Infectious Diseases |